| Dr Stacy J Taylor, MD | |
|
333 Kennedy Dr, Suite L-201, Torrington, CT 06790-3060 | |
| (860) 482-0261 | |
| (860) 482-6301 |
| Full Name | Dr Stacy J Taylor |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 26 Years |
| Location | 333 Kennedy Dr, Torrington, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104837483 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 040104 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Foothills Visiting Nurse And H | Winsted, CT | Hospice |
| Saint Mary's Hospital | Waterbury, CT | Hospital |
| St Francis Hospital & Medical Center | Hartford, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Asylum Hill Family Medicine Center, Inc. | 9032016134 | 21 |
| Trinity Health Of New England Provider Network Organization Inc | 0941113567 | 621 |
News Archive
House Ways and Means Committee Chairman Dave Camp, R-Mich, announced on Monday that he will retire in 2014, ending a 12-term congressional career. Camp was a powerful voice in federal health, welfare , trade policy and tax reform.
Redpoint Bio Corporation, a company focused on the development of healthier foods and beverages and new approaches to the treatment of diabetes and obesity, today announced the issuance of Patent No. 7,749,730 B2 by the U.S. Patent and Trademark Office entitled "High Throughput Screening Assay for the TRPm5 Ion Channel."
Transition Therapeutics Inc. announced that its wholly owned subsidiary, Transition Therapeutics Ireland Limited completed enrolment of the Phase 2 clinical study evaluating neuropsychiatric drug candidate ELND005 as a treatment for agitation and aggression in patients with mild, moderate and severe Alzheimer's disease ("AD").
Denis Anson, M.S., O.T.R., director of research and development for the Assistive Technology Research Institute (ATRI) at Misericordia University, has worn a lot of different hats in his professional career.By utilizing the expertise he's acquired during his 30 years of practice and application of assistive technology and occupational therapy strategies, Anson has devised and brought to market the Americans with Disabilities Act — Compliance Assessment Toolkit or ADA-CAT to measure whether public facilities are in compliance with the federal law that was enacted 20 years ago.
A powerful new drug to treat malaria - the invention of a University of Nebraska Medical Center College of Pharmacy researcher - will help take the bite out of malaria. In the United States, a mosquito bite seems harmless, but in developing countries it means more than 655,000 deaths a year - mostly in children.
› Verified 2 days ago
| Entity Name | Trinity Health Of New England Provider Network Organization Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003882812 PECOS PAC ID: 0941113567 Enrollment ID: O20031110000651 |
News Archive
House Ways and Means Committee Chairman Dave Camp, R-Mich, announced on Monday that he will retire in 2014, ending a 12-term congressional career. Camp was a powerful voice in federal health, welfare , trade policy and tax reform.
Redpoint Bio Corporation, a company focused on the development of healthier foods and beverages and new approaches to the treatment of diabetes and obesity, today announced the issuance of Patent No. 7,749,730 B2 by the U.S. Patent and Trademark Office entitled "High Throughput Screening Assay for the TRPm5 Ion Channel."
Transition Therapeutics Inc. announced that its wholly owned subsidiary, Transition Therapeutics Ireland Limited completed enrolment of the Phase 2 clinical study evaluating neuropsychiatric drug candidate ELND005 as a treatment for agitation and aggression in patients with mild, moderate and severe Alzheimer's disease ("AD").
Denis Anson, M.S., O.T.R., director of research and development for the Assistive Technology Research Institute (ATRI) at Misericordia University, has worn a lot of different hats in his professional career.By utilizing the expertise he's acquired during his 30 years of practice and application of assistive technology and occupational therapy strategies, Anson has devised and brought to market the Americans with Disabilities Act — Compliance Assessment Toolkit or ADA-CAT to measure whether public facilities are in compliance with the federal law that was enacted 20 years ago.
A powerful new drug to treat malaria - the invention of a University of Nebraska Medical Center College of Pharmacy researcher - will help take the bite out of malaria. In the United States, a mosquito bite seems harmless, but in developing countries it means more than 655,000 deaths a year - mostly in children.
› Verified 2 days ago
| Entity Name | Asylum Hill Family Medicine Center, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083660096 PECOS PAC ID: 9032016134 Enrollment ID: O20031217000249 |
News Archive
House Ways and Means Committee Chairman Dave Camp, R-Mich, announced on Monday that he will retire in 2014, ending a 12-term congressional career. Camp was a powerful voice in federal health, welfare , trade policy and tax reform.
Redpoint Bio Corporation, a company focused on the development of healthier foods and beverages and new approaches to the treatment of diabetes and obesity, today announced the issuance of Patent No. 7,749,730 B2 by the U.S. Patent and Trademark Office entitled "High Throughput Screening Assay for the TRPm5 Ion Channel."
Transition Therapeutics Inc. announced that its wholly owned subsidiary, Transition Therapeutics Ireland Limited completed enrolment of the Phase 2 clinical study evaluating neuropsychiatric drug candidate ELND005 as a treatment for agitation and aggression in patients with mild, moderate and severe Alzheimer's disease ("AD").
Denis Anson, M.S., O.T.R., director of research and development for the Assistive Technology Research Institute (ATRI) at Misericordia University, has worn a lot of different hats in his professional career.By utilizing the expertise he's acquired during his 30 years of practice and application of assistive technology and occupational therapy strategies, Anson has devised and brought to market the Americans with Disabilities Act — Compliance Assessment Toolkit or ADA-CAT to measure whether public facilities are in compliance with the federal law that was enacted 20 years ago.
A powerful new drug to treat malaria - the invention of a University of Nebraska Medical Center College of Pharmacy researcher - will help take the bite out of malaria. In the United States, a mosquito bite seems harmless, but in developing countries it means more than 655,000 deaths a year - mostly in children.
› Verified 2 days ago
| Entity Name | The Charlotte Hungerford Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629075734 PECOS PAC ID: 4486557501 Enrollment ID: O20040128000183 |
News Archive
House Ways and Means Committee Chairman Dave Camp, R-Mich, announced on Monday that he will retire in 2014, ending a 12-term congressional career. Camp was a powerful voice in federal health, welfare , trade policy and tax reform.
Redpoint Bio Corporation, a company focused on the development of healthier foods and beverages and new approaches to the treatment of diabetes and obesity, today announced the issuance of Patent No. 7,749,730 B2 by the U.S. Patent and Trademark Office entitled "High Throughput Screening Assay for the TRPm5 Ion Channel."
Transition Therapeutics Inc. announced that its wholly owned subsidiary, Transition Therapeutics Ireland Limited completed enrolment of the Phase 2 clinical study evaluating neuropsychiatric drug candidate ELND005 as a treatment for agitation and aggression in patients with mild, moderate and severe Alzheimer's disease ("AD").
Denis Anson, M.S., O.T.R., director of research and development for the Assistive Technology Research Institute (ATRI) at Misericordia University, has worn a lot of different hats in his professional career.By utilizing the expertise he's acquired during his 30 years of practice and application of assistive technology and occupational therapy strategies, Anson has devised and brought to market the Americans with Disabilities Act — Compliance Assessment Toolkit or ADA-CAT to measure whether public facilities are in compliance with the federal law that was enacted 20 years ago.
A powerful new drug to treat malaria - the invention of a University of Nebraska Medical Center College of Pharmacy researcher - will help take the bite out of malaria. In the United States, a mosquito bite seems harmless, but in developing countries it means more than 655,000 deaths a year - mostly in children.
› Verified 2 days ago
| Entity Name | Hartford Healthcare Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043561301 PECOS PAC ID: 1153573902 Enrollment ID: O20121201000007 |
News Archive
House Ways and Means Committee Chairman Dave Camp, R-Mich, announced on Monday that he will retire in 2014, ending a 12-term congressional career. Camp was a powerful voice in federal health, welfare , trade policy and tax reform.
Redpoint Bio Corporation, a company focused on the development of healthier foods and beverages and new approaches to the treatment of diabetes and obesity, today announced the issuance of Patent No. 7,749,730 B2 by the U.S. Patent and Trademark Office entitled "High Throughput Screening Assay for the TRPm5 Ion Channel."
Transition Therapeutics Inc. announced that its wholly owned subsidiary, Transition Therapeutics Ireland Limited completed enrolment of the Phase 2 clinical study evaluating neuropsychiatric drug candidate ELND005 as a treatment for agitation and aggression in patients with mild, moderate and severe Alzheimer's disease ("AD").
Denis Anson, M.S., O.T.R., director of research and development for the Assistive Technology Research Institute (ATRI) at Misericordia University, has worn a lot of different hats in his professional career.By utilizing the expertise he's acquired during his 30 years of practice and application of assistive technology and occupational therapy strategies, Anson has devised and brought to market the Americans with Disabilities Act — Compliance Assessment Toolkit or ADA-CAT to measure whether public facilities are in compliance with the federal law that was enacted 20 years ago.
A powerful new drug to treat malaria - the invention of a University of Nebraska Medical Center College of Pharmacy researcher - will help take the bite out of malaria. In the United States, a mosquito bite seems harmless, but in developing countries it means more than 655,000 deaths a year - mostly in children.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stacy J Taylor, MD 893 Main St Ste 101, East Hartford, CT 06108-2293 Ph: (860) 528-2138 | Dr Stacy J Taylor, MD 333 Kennedy Dr, Suite L-201, Torrington, CT 06790-3060 Ph: (860) 482-0261 |
News Archive
House Ways and Means Committee Chairman Dave Camp, R-Mich, announced on Monday that he will retire in 2014, ending a 12-term congressional career. Camp was a powerful voice in federal health, welfare , trade policy and tax reform.
Redpoint Bio Corporation, a company focused on the development of healthier foods and beverages and new approaches to the treatment of diabetes and obesity, today announced the issuance of Patent No. 7,749,730 B2 by the U.S. Patent and Trademark Office entitled "High Throughput Screening Assay for the TRPm5 Ion Channel."
Transition Therapeutics Inc. announced that its wholly owned subsidiary, Transition Therapeutics Ireland Limited completed enrolment of the Phase 2 clinical study evaluating neuropsychiatric drug candidate ELND005 as a treatment for agitation and aggression in patients with mild, moderate and severe Alzheimer's disease ("AD").
Denis Anson, M.S., O.T.R., director of research and development for the Assistive Technology Research Institute (ATRI) at Misericordia University, has worn a lot of different hats in his professional career.By utilizing the expertise he's acquired during his 30 years of practice and application of assistive technology and occupational therapy strategies, Anson has devised and brought to market the Americans with Disabilities Act — Compliance Assessment Toolkit or ADA-CAT to measure whether public facilities are in compliance with the federal law that was enacted 20 years ago.
A powerful new drug to treat malaria - the invention of a University of Nebraska Medical Center College of Pharmacy researcher - will help take the bite out of malaria. In the United States, a mosquito bite seems harmless, but in developing countries it means more than 655,000 deaths a year - mostly in children.
› Verified 2 days ago
Clifford B Rosenberg, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 333 Kennedy Drive, Foothills Family Medicine, Torrington, CT 06790 Phone: 860-489-3449 Fax: 860-489-0448 | |
Dr. Stephanie K Fowler, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 157 Litchfield St, Torrington, CT 06790 Phone: 860-489-0931 Fax: 860-489-3325 | |
Dr. Lanny Moskowitz, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 333 Kennedy Dr, Suite L104, Torrington, CT 06790 Phone: 860-626-1141 Fax: 860-626-8911 | |
Frank A Crociata, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 434 Prospect St, Torrington, CT 06790 Phone: 860-482-1950 Fax: 860-482-0621 | |
Dr. D. James Mckay, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 990 Migeon Ave, Torrington, CT 06790 Phone: 860-482-8556 Fax: 860-626-0361 | |
Bradley L. Rosenberg, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 333 Kennedy Dr, Suite L-104, Torrington, CT 06790 Phone: 860-496-4043 Fax: 860-496-4046 |